95 related articles for article (PubMed ID: 12888596)
1. A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs.
Gosling RD; Heifets L; Gillespie SH
J Antimicrob Chemother; 2003 Sep; 52(3):473-6. PubMed ID: 12888596
[TBL] [Abstract][Full Text] [Related]
2. A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens.
Gillespie SH; Charalambous BM
Int J Tuberc Lung Dis; 2003 Jul; 7(7):684-9. PubMed ID: 12870691
[TBL] [Abstract][Full Text] [Related]
3. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
[TBL] [Abstract][Full Text] [Related]
4. A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.
Gillespie SH; Gosling RD; Charalambous BM
Am J Respir Crit Care Med; 2002 Jul; 166(1):31-5. PubMed ID: 12091167
[TBL] [Abstract][Full Text] [Related]
5. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
Donald PR; Diacon AH
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
[TBL] [Abstract][Full Text] [Related]
6. The early bactericidal activity of amikacin in pulmonary tuberculosis.
Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580
[TBL] [Abstract][Full Text] [Related]
7. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.
Gosling RD; Uiso LO; Sam NE; Bongard E; Kanduma EG; Nyindo M; Morris RW; Gillespie SH
Am J Respir Crit Care Med; 2003 Dec; 168(11):1342-5. PubMed ID: 12917230
[TBL] [Abstract][Full Text] [Related]
8. Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.
Hafner R; Cohn JA; Wright DJ; Dunlap NE; Egorin MJ; Enama ME; Muth K; Peloquin CA; Mor N; Heifets LB
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):918-23. PubMed ID: 9310014
[TBL] [Abstract][Full Text] [Related]
9. The early bactericidal activity of streptomycin.
Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Doré CJ; Mitchison DA
Int J Tuberc Lung Dis; 2002 Aug; 6(8):693-8. PubMed ID: 12150481
[TBL] [Abstract][Full Text] [Related]
10. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
Diacon AH; Dawson R; Hanekom M; Narunsky K; Venter A; Hittel N; Geiter LJ; Wells CD; Paccaly AJ; Donald PR
Int J Tuberc Lung Dis; 2011 Jul; 15(7):949-54. PubMed ID: 21682970
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
12. The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.
Sirgel FA; Botha FJ; Parkin DP; Van de Wal BW; Schall R; Donald PR; Mitchison DA
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):901-5. PubMed ID: 9310011
[TBL] [Abstract][Full Text] [Related]
13. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
Wallis RS; Vinhas SA; Johnson JL; Ribeiro FC; Palaci M; Peres RL; Sá RT; Dietze R; Chiunda A; Eisenach K; Ellner JJ
J Infect Dis; 2003 Jan; 187(2):270-8. PubMed ID: 12552451
[TBL] [Abstract][Full Text] [Related]
14. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S
J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
[TBL] [Abstract][Full Text] [Related]
18. Optimal sampling strategies for early pharmacodynamic measures in tuberculosis.
Davies GR; Khoo SH; Aarons LJ
J Antimicrob Chemother; 2006 Sep; 58(3):594-600. PubMed ID: 16857690
[TBL] [Abstract][Full Text] [Related]
19. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
[TBL] [Abstract][Full Text] [Related]
20. Clinical development of anti-tuberculosis drugs.
Mitchison DA
J Antimicrob Chemother; 2006 Sep; 58(3):494-5. PubMed ID: 16840430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
